Phase I study of temsirolimus (CCI-779) and sorafenib in recurrent glioblastoma: North central cancer treatment group (NCCTG) N0572

被引：0

作者：

Schiff, David ^{[1
]}

Sarkaria, Jann ^{[2
]}

Decker, Paul ^{[2
]}

Buckner, Jan ^{[2
]}

Galanis, Evanthia ^{[2
]}

Dancey, Janet ^{[3
]}

Giannini, Caterina ^{[2
]}

Brown, Paul ^{[2
]}

Wiesenfeld, Martin ^{[4
]}

Jaeckle, Kurt ^{[5
]}

机构：

[1] Univ Virginia, Hlth Sci Ctr, Charlottesville, VA USA

[2] Mayo Clin, Rochester, MN USA

[3] Natl Canc Inst, Bethesda, MD USA

[4] Cedar Rapids Oncol Project, Cedar Rapids, IA USA

[5] Mayo Clin, Jacksonville, FL 32224 USA

来源：

NEURO-ONCOLOGY | 2007年 / 9卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：518 / 518

页数：1

共 50 条

[31] Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study [J].

Alberts, SR ;

Townley, PM ;

Goldberg, RM ;

Cha, SS ;

Moore, DF ;

Krook, JE ;

Pitot, HC ;

Fitch, TR ;

Wiesenfeld, M ;

Mailliard, JA ;

Sargent, DJ .

ANNALS OF ONCOLOGY, 2002, 13 (04) :553-557

[32] N997B: Phase II trial of CCI-779 in recurrent glioblastoma multiforme (GBM): Updated results and correlative laboratory analysis. [J].

Galanis, E ;

Buckner, JC ;

Maurer, MJ ;

Hidalgo, M ;

Kreisberg, JI ;

Peralba, J ;

Jenkins, RB ;

Walsh, DJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :115S-115S

[33] Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199) [J].

Tinker, A. V. ;

Ellard, S. ;

Welch, S. ;

Moens, F. ;

Allo, G. ;

Tsao, M. S. ;

Squire, J. ;

Tu, D. ;

Eisenhauer, E. A. ;

MacKay, H. .

GYNECOLOGIC ONCOLOGY, 2013, 130 (02) :269-274

[34] Anti-tumor activity of low-dose single agent CCI-779 for relapsed mantle cell/Lymphoma: A phase II trial in the North Central Cancer Treatment Group. [J].

Witzig, TE ;

Ansell, SM ;

Geyer, SM ;

Kurtin, PJ ;

Rowland, KM ;

Flynn, PJ ;

Morton, RF ;

Dakhil, SR ;

Gross, HM ;

Maurer, MJ ;

Kaufmann, SH .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :561S-561S

[35] Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study [J].

Friday, Bret B. ;

Anderson, S. Keith ;

Buckner, Jan ;

Yu, Chunrong ;

Giannini, Caterina ;

Geoffroy, Francois ;

Schwerkoske, John ;

Mazurczak, Miroslaw ;

Gross, Howard ;

Pajon, Eduardo ;

Jaeckle, Kurt ;

Galanis, Evanthia .

NEURO-ONCOLOGY, 2012, 14 (02) :215-221

[36] Phase I/II study of sorafenib and temsirolimus for patients with recurrent glioblastoma (GBM) (NABTC 05-02) [J].

Wen, P. Y. ;

Cloughesy, T. ;

Kuhn, J. ;

Lamborn, K. ;

Abrey, L. E. ;

Lieberman, F. ;

Robins, H. I. ;

Wright, J. ;

Prados, M. D. ;

Gilbert, M. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

[37] Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02 [J].

Lee, Eudocia Q. ;

Kuhn, John ;

Lamborn, Kathleen R. ;

Abrey, Lauren ;

DeAngelis, Lisa M. ;

Lieberman, Frank ;

Robins, H. Ian ;

Chang, Susan M. ;

Yung, W. K. Alfred ;

Drappatz, Jan ;

Mehta, Minesh P. ;

Levin, Victor A. ;

Aldape, Kenneth ;

Dancey, Janet E. ;

Wright, John J. ;

Prados, Michael D. ;

Cloughesy, Timothy F. ;

Gilbert, Mark R. ;

Wen, Patrick Y. .

NEURO-ONCOLOGY, 2012, 14 (12) :1511-1518

[38] PHASE II TRIAL OF VORINOSTAT IN COMBINATION WITH BORTEZOMIB IN RECURRENT GLIOBLASTOMA MULTIFORME: A NORTH CENTRAL CANCER TREATMENT GROUP STUDY [J].

Friday, Bret B. ;

Buckner, Jan ;

Anderson, S. Keith ;

Giannini, Caterina ;

Kugler, John ;

Mazurczac, Miroslaw ;

Flynn, Patrick ;

Gross, Howard ;

Pajon, Eduardo ;

Jaeckle, Kurt ;

Galanis, Evanthia .

NEURO-ONCOLOGY, 2010, 12 :70-70

[39] IS RESPONSE A MEANINGFUL SURROGATE FOR SURVIVAL FNDPOINTS IN CLINICAL TRIALS INVOLVING NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA PATIENTS? A NORTH CENTRAL CANCER TREATMENT GROUP (NCCTG) STUDY [J].

Jaeckle, Kurt ;

Xu, Wenting ;

Ballaman, Karla ;

Flynn, Patrick ;

Buchner, Jan .

NEURO-ONCOLOGY, 2008, 10 (05) :842-843

[40] Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: A north central cancer treatment group (NCCTG) phase i and II trial, N9943 [J].

Alberts S.R. ;

Sande J.R. ;

Foster N.R. ;

Quevedo F.J. ;

McWilliams R.R. ;

Kugler J.W. ;

Fitch T.R. ;

Jaslowski A.J. .

Journal of Gastrointestinal Cancer, 2007, 38 (2-4) :87-94

← 1 2 3 4 5 →